Description

Session will include operational aspects related to the manufacturing and testing of Hematopoietic Progenitor Cell products, including peripheral blood stems cells, cord blood, and bone marrow In addition, management of the cell therapy facility for manufacturing operations will be included in discussions.

Learning Objectives:

• Distinguish between the various processing methods used in manufacturing operations within a cell therapy facility.
• Design cellular therapy product testing methods to ensure quality control of released products.
• Apply cell therapy manufacturing controls to ensure quality control during operations.

Speaker(s):

• Mike Halpenny, Canadian Blood Services
• Ronit Slotky, PhD, Hackensack University Medical Center
• Ljiljana V. Vasovic, M.D., Weill Cornell Medicine Department of Pathology and Laboratory Medicine